Shree Ganesh Remedies Share Price Today | Stock Price & Shree Ganesh Remedies Share Screener
As of October 5, 2026, the live Shree Ganesh Remedies share price (NSE: SGRL) is ₹680.40 on NSE and ₹681.90 on BSE, down 1.99% from the previous close, with shares trading between ₹669.05 and ₹709.30 in today's trading session, and a 52-week range of ₹501.05–₹735.55. Check Shree Ganesh Remedies yearly highs lows for the annual price range and momentum. Use the Shree Ganesh Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Shree Ganesh Remedies opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹34 and net income of ₹6, with EBITDA of ₹12, an operating margin of 34.0% and a profit margin of 17.7%.
Shree Ganesh Remedies Share Price Chart
Track the current stock price of Shree Ganesh Remedies with an interactive chart. Analyse SGRL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Shree Ganesh Remedies stock quote in one place.
The quote of ₹680.40 sits between the 52-week low of ₹501.05 and the 52-week high of ₹735.55, and the latest session moved -1.99% from the previous close.
Shree Ganesh Remedies Company Profile - Fundamental Screener
Screen Shree Ganesh Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SGRL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE414Y01015.
Company Details
Classification
Identifiers and Leadership
Shree Ganesh Remedies Balance Sheet Screener
Screen SGRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹208, up from ₹192 in 2025.
Latest statistics put total assets at ₹208 and shareholder funds at ₹163, with a leverage ratio of 0.22.
| Item | 2026 | 2025 | 2024 | 2020 | 2019 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 208 | 192 | 171 | 55 | 41 |
| Current Assets | 86 | 78 | 70 | 34 | 26 |
| Fixed Assets | 105 | 95 | 81 | 20 | 15 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 23 | 31 | 30 | 3 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 163 | 145 | 122 | 42 | 34 |
| Share Capital | 13 | 13 | 13 | 9 | 9 |
| Reserves & Surplus | 150 | 132 | 109 | 33 | 25 |
Shree Ganesh Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Shree Ganesh Remedies income statement and profit fundamentals. Analyze SGRL quarterly results. Shree Ganesh Remedies reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹34 and net profit was ₹6, equal to earnings per unit of ₹4.88, at an operating margin of 34%.
In that period expenses were ₹22, interest cost ₹1 and tax ₹3. The next period listed, 2026-Jun, shows revenue of ₹15 and net profit of ₹1.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2021-Mar | 2021-Jun | 2021-Sept | 2021-Dec | 2020-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 34 | 15 | 27 | 25 | 31 | 22 | 39 | 25 | 33 | 28 | 16 | 14 | 17 | 22 | 10 |
| Expenses | 22 | 11 | 15 | 17 | 21 | 14 | 20 | 17 | 21 | 17 | 10 | 10 | 13 | 15 | 8 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 12 | 4 | 12 | 8 | 10 | 7 | 18 | 9 | 12 | 11 | 5 | 4 | 5 | 7 | 2 |
| Operating Profit % | 34.00% | 23.00% | 40.00% | 30.00% | 32.00% | 32.00% | 45.00% | 33.00% | 35.00% | 37.00% | 33.00% | 24.00% | 26.00% | 27.00% | 12.00% |
| Depreciation | 3 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 9 | 2 | 9 | 5 | 7 | 4 | 16 | 6 | 9 | 8 | 4 | 3 | 4 | 6 | 1 |
| Tax | 3 | 0 | 2 | 1 | 2 | 1 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 6 | 1 | 7 | 4 | 5 | 3 | 13 | 5 | 6 | 5 | 3 | 2 | 3 | 4 | 1 |
| EPS | 4.88 | 0.87 | 5.13 | 2.68 | 3.86 | 2.41 | 10.01 | 3.62 | 4.97 | 4.22 | 3.03 | 4.68 | 3.02 | 3.50 | 0.85 |
Shree Ganesh Remedies Cash Flow Screener - Liquidity Fundamentals
Screen SGRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹24, and net cash flow was an inflow of ₹4.
Over the same period, investing activities used ₹9 and financing activities used ₹12.
| Item | 2026-March | 2025-March | 2024-March | 2020-March | 2019-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 24 | 31 | 31 | 5 | -5 |
| Investing Activities | -9 | -36 | -33 | -3 | 0 |
Financing and Net Cash | |||||
| Financing Activities | -12 | -1 | 10 | -1 | 0 |
| Net Cash Flow | 4 | -6 | 7 | 1 | -6 |
Shree Ganesh Remedies Shareholding Pattern Screener
See Shree Ganesh Remedies shareholding pattern with promoter, FII, and DII holdings. Check Shree Ganesh Remedies promoter holding and ownership changes for SGRL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 72.84%, foreign institutions 0.00%, domestic institutions 0.00% and the public 24.97%, spread across 8,058 shareholders.
The shareholder count was 8,058 in 2026-Mar, compared with 7,822 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 72.84% | 72.84% | 72.80% | 72.80% | 72.80% | 72.80% | 69.33% | 69.33% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.01% |
| DII Holding | 0.00% | 0.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.97% | 24.63% | 24.89% | 24.87% | 24.92% | 24.95% | 28.14% | 28.51% |
| Other Holding | 2.19% | 2.01% | 2.31% | 2.32% | 2.27% | 2.25% | 2.53% | 2.15% |
| Shareholder Count | 8,058 | 7,822 | 8,978 | 9,166 | 8,752 | 8,442 | 7,049 | 7,186 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Shree Ganesh Remedies. Shree Ganesh Remedies dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.50 | 0.07% |
| 2023-March | ₹0.30 | 0.04% |
| 2022-March | ₹0.50 | 0.20% |
| 2021-March | ₹1.75 | 0.59% |
| 2020-March | ₹1.50 | 0.54% |
| 2019-March | ₹1.25 | 2.32% |
| 2018-March | ₹1.00 | 2.49% |
| 2017-March | ₹0.00 | 0.00% |
Shree Ganesh Remedies Stock Index Membership - Nifty & Sensex
See which indices include Shree Ganesh Remedies stock. Check SGRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Shree Ganesh Remedies Market Events Screener - Corporate Actions
Get Shree Ganesh Remedies corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Shree Ganesh Remedies stock events that may affect SGRL share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 12, 2026, with a record date of September 12, 2026.
It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated May 14, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-12 | 2026-09-12 | Annual General Meeting | NA | 26.13% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 0.29% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -5.03% |
| 2026-04-06 | 2026-04-06 | Extraordinary General Meeting | NA | -6.96% |
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | -3.18% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -0.77% |
| 2025-09-09 | 2025-09-09 | Annual General Meeting | NA | 4.64% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -3.35% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 3.44% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 33.42% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.34% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -5.12% |
| 2023-09-07 | 2023-09-07 | Dividend | ₹ 0.50 /share | 52.75% |
| 2023-02-03 | 2023-02-03 | Rights | 7:100 | -2.38% |
| 2022-09-15 | 2022-09-16 | Dividend | ₹ 0.50 /share | -19.88% |
Shree Ganesh Remedies Competitors Screener - Peer Stocks Comparison
Screen SGRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Shree Ganesh Remedies Company Announcements - News & Reports Screener
Screen SGRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 3, 2026.
The next most recent announcements are dated September 12, 2026 and September 12, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-03 | Closure of Trading Window | - |
| 2026-09-12 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-12 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-20 | Reg. 34 (1) Annual Report. | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-12 | Appointment Of Cost Auditors | - |
| 2026-08-12 | Results - Financial Results For The Quarter Ended On June 30 2026 | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-08 | Board Meeting Intimation for The Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter Ended On June 30 2026 | - |
| 2026-07-17 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-29 | Clarification On Price Movement | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-25 | Clarification sought from Shree Ganesh Remedies Ltd | - |
| 2026-05-25 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹680.40, within a 52-week range of ₹501.05 to ₹735.55. The P/E ratio is 56.50 and the P/B ratio is 5.35, with earnings per unit of ₹13.83. Market capitalisation stands at ₹854.48 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.